← All educational resources

Why Your Body Forgets How to Stand Up: POTS and Dysautonomia

2026-10-31

Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.

Print the one-page card (PDF): the levers, up front, on a single sheet.

Wallet-size medical information card to fill in with your clinician: POTS (10-up sheet) · POTS + MCAS + hypermobility (10-up sheet).

What is happening

Your body has an autopilot. It is called the autonomic nervous system, and it runs the things you never think about: your heartbeat, your blood pressure, how your blood vessels squeeze or relax, how fast food moves through your gut, whether you sweat, how big your pupils are.

When you stand up, gravity pulls your blood down into your legs. A healthy autopilot notices this in about one second and squeezes the blood vessels in your legs to push blood back up to your heart and brain. You never feel it happen.

In POTS and other kinds of dysautonomia, that autopilot is not answering the phone. The blood stays in your legs. Your brain gets less blood. So your heart does the only thing it can do on its own: it beats faster, sometimes 30 or 40 beats faster, to try to move the blood that is left. That is why you feel your heart pounding, feel dizzy, see spots, get shaky, feel sick to your stomach, or feel like you are going to pass out when you stand.

That is the "what." Most people with POTS have been told the "what" many times. What they have not been told is the "why."

Why the autopilot stops answering

The autopilot sends its orders through the smallest nerves in your body. They are called small fibers, and they are so thin that a regular nerve test cannot see them. They run to every blood vessel, every sweat gland, and your gut.

In many people with POTS, those tiny nerves are damaged or dying back. Doctors call this small fiber neuropathy. In my research consulting work, I see three things stacked on top of each other in almost everyone who has it. I think of them as three weights on a shelf. One weight the shelf can hold. Three and it breaks.

Weight one: the nerves are not getting fed. Nerves are made of fat and protein, and they need a steady supply of certain nutrients to repair themselves every single day: vitamin B12, folate, B1, B6, B2, omega-3 fats, choline, copper, vitamin E, magnesium, and iron. If you are low in even a few of these, the nerves cannot keep up with repairs. Many of the people I have worked with are low in several, often because their gut is not absorbing well, or because their genes make them need more than the average person.

Weight two: mast cells are spraying chemicals on the nerves. Mast cells are immune cells that live in your skin, gut, and around your blood vessels. Their job is to release histamine and other chemicals when there is a threat. In a lot of people with POTS, the mast cells are jumpy and release those chemicals all the time: after meals, in heat, with stress, after exercise. Histamine makes blood vessels leaky and wide (the opposite of what you need when you stand), and the other chemicals irritate the small nerves. If you flush, get hives, react to foods, have a runny nose for no reason, or feel wired after eating, your mast cells are probably part of your story.

Weight three: the repair crew is overwhelmed. Your body has a chemical process called methylation. It is how you build nerve insulation, make brain chemicals, clear out histamine, and recycle used-up molecules. It runs on folate and B12. When you are fighting off something for months (a virus, a chronic infection, stress, toxins), methylation gets used up faster than you can refill it. Then histamine does not get cleared, nerves do not get rebuilt, and the whole thing spirals. Many of the people I have worked with also have gene variants that make this process slower to begin with.

Put those three together and you get small nerves that are hungry, being irritated, and not being repaired. The autopilot goes quiet. The heart races to make up for it.

Two more pieces fit this picture. Many of the POTS cases I have worked through are bendy (hypermobile), with loose joints and stretchy skin. Loose connective tissue means loose blood vessels that let more blood pool, which makes the whole problem worse. And a lot of people date their symptoms to a COVID infection. I think COVID did not cause a new disease so much as it pushed people who were already carrying two weights into carrying three.

The good news

Small nerves can grow back. It is slow. It takes months, not weeks. But unlike the big nerves, small fibers regenerate if you feed them, stop irritating them, and give the repair crew what it needs. That is the whole plan.

What the model predicts would help, and why

1. Feed the nerves (diet)

The working rule in this model for nerve repair is roughly one and a half times the normal daily amount of the nutrients that build nerves, from food first, as long as your kidneys and liver are healthy. Spread over the day, that works out to a target for each meal. I list the target, a meal that hits it, and swaps for people who cannot eat eggs, fish, or organ meat.

Breakfast target: 25 to 30 g protein, about 250 mg choline, a good hit of B12 and B2, some magnesium, and salt.

  • Meal: two eggs cooked in butter or olive oil, half an avocado, a handful of berries, salted well.
  • No eggs? Swap for 4 ounces of chicken thigh or ground beef (choline, B12), or 1 cup of cottage cheese or Greek yogurt plus a tablespoon of sunflower lecithin stirred into anything (that is the choline, which is the hardest nutrient to replace when eggs come out).

Lunch target: 25 to 30 g protein, 1 to 1.5 g of omega-3 (EPA plus DHA), about 200 mcg folate, magnesium, copper, and iron.

  • Meal: a big salad with 3 to 4 ounces of sardines or wild salmon, a cup of lentils or white beans, pumpkin seeds, olive oil and lemon.
  • Worried about mercury in canned fish? That is a fair concern if your detox pathways are slow. Mercury tracks with the size and age of the fish, so pick the small ones: sardines, herring, anchovies, and Atlantic mackerel are the lowest. Canned salmon is low-moderate; fresh or frozen wild salmon and trout are a cleaner swap. Skip tuna, swordfish, and king mackerel entirely.
  • No fish at all? Get the omega-3 from an algae-based DHA/EPA supplement with the meal, and get the folate, iron, and copper from the lentils, beans, pumpkin seeds, and a cup of cooked greens.

Dinner target: 30 to 35 g protein, B12, B1, B6, heme iron, zinc, and about 200 mcg folate from a green vegetable.

  • Meal: 5 to 6 ounces of beef, lamb, or chicken thigh, a cup of broccoli or asparagus, and a baked potato or a cup of rice with salt and butter.
  • No red meat? Chicken thigh or turkey for the B vitamins, plus the folate greens and a cup of beans for the iron. Pair the beans with something containing vitamin C (bell pepper, lemon, tomato if you tolerate it) so the iron absorbs.

Snacks: a small handful of sunflower seeds (vitamin E, B1), a hard-boiled egg or a few slices of turkey, a cup of bone broth with a pinch of extra salt.

Liver, once or twice a week: beef or chicken liver is the single richest source of B12, folate, copper, B2, and vitamin A you can eat, and 2 to 3 ounces a week is enough. If you cannot face it whole, chop it fine into ground beef, or use desiccated liver capsules. The math: drying takes out about three quarters of the weight, so roughly 4 grams of dried liver equals 1 ounce fresh. Most brands are 500 to 750 mg per capsule, so 2 to 3 ounces of liver a week is about 12 to 18 capsules a week, or 2 to 3 capsules a day with food. Look for grass-fed, freeze-dried liver with no fillers.

Salt and water: this is the one POTS instruction most people have heard, and it is correct. Aim for 2 to 3 liters of water a day and 6 to 10 grams of salt (1 to 2 teaspoons, spread across the day), unless your doctor has told you to limit salt. Put a quarter teaspoon of salt in your first glass of water in the morning, before you stand up for the day.

If your mast cells are jumpy: cut the biggest histamine sources for four weeks and see what changes. The big ones are leftovers more than a day old, aged cheese, cured meat, wine and beer, fermented foods like sauerkraut and kombucha, vinegar, canned fish once it has been open more than a day, tomatoes, spinach, and eggplant. Cook fresh, eat it, and freeze the rest the same day. Freezing stops histamine from building up; the fridge does not.

Protein at every meal and never skip breakfast. Low blood sugar makes the autopilot worse.

2. Supplements, in the order the model suggests

The working rule is supplements as low as possible and food first. These are the ones the model points to most often, in the order I usually add them. Add one at a time, a week apart, so you know what is doing what.

  1. Magnesium (glycinate or malate powder), 200 mg at night to start, up to 400 mg. Calms nerves and mast cells and helps you sleep.
  2. Omega-3 fish oil, 2 grams of EPA plus DHA a day, always with a meal that has some fat in it. On an empty stomach most of it passes through unabsorbed. This is the raw material for nerve membranes.
  3. Creatine monohydrate, 5 grams a day, and phosphatidylcholine, 1,200 to 2,400 mg a day with food. This pair is my replacement for the methylated B complex most people are handed. Here is why. Your body spends almost half of its methylation budget making creatine and a big share of the rest making phosphatidylcholine for cell membranes. If you eat both ready-made, that budget is freed up for the jobs we actually care about: clearing histamine and rebuilding nerves. You get the benefit without pushing methyl groups into a system that may not be able to use them.
  4. A plain (non-methylated) B complex with folinic acid, started at a quarter dose and raised a quarter dose each week. Folinic acid is a form of folate that your body converts into the active form only as fast as it can use it, so it does not cause what I call methyl trapping.

What is methyl trapping? Methylfolate and methyl-B12 are "pre-loaded" with a methyl group. If the next steps in the chain are slow (low B2, low magnesium, a slow COMT gene, a system that is already overwhelmed), those methyl groups pile up with nowhere to go. People feel it as sudden anxiety, insomnia, irritability, a racing heart, or a headache within a day or two of starting. If that happens to you, stop, let it clear for a few days, and use the folinic acid form instead. It enters the chain one step earlier and lets your body set the pace. 5. Vitamin B12, 1,000 mcg under the tongue daily. Use hydroxocobalamin plus adenosylcobalamin as your default; neither carries a methyl group, so they are safe for methyl-sensitive people. If you know you tolerate methyl forms well, adenosylcobalamin plus methylcobalamin is also fine. Nerves need a lot of B12. 6. Mitochondrial support, because repairing nerves takes energy and the power plants in POTS are usually struggling too: CoQ10 (ubiquinol) 100 to 200 mg with a meal, then acetyl-L-carnitine 500 to 1,000 mg in the morning, then alpha-lipoic acid 300 to 600 mg. Skip the alpha-lipoic acid if you are pregnant, planning to become pregnant, or breastfeeding; the other two are fine. 7. Vitamin C, liposomal, 1,000 mg a day. It steadies mast cells and your body uses it to make the stress hormones that hold blood pressure up. 8. Apigenin, 50 mg at night, for jumpy mast cells. It is a plant compound from chamomile and parsley that calms mast cells and also helps you fall asleep, which is why it goes at bedtime rather than with meals. Add vitamin E as mixed tocotrienols (all four forms) a few weeks later if flushing and nerve pain are a big part of your picture. 9. Iron, only if your ferritin is under about 50. Low iron alone can cause a racing heart on standing.

3. Lifestyle, which is at least half the lever

  • Retrain the autopilot with exercise you do lying down or sitting. This is the single most effective approach that exists for POTS, and it only works if you start low enough that you do not crash. Month one: recumbent bike or rowing machine, 10 minutes, three times a week, easy enough to talk the whole time. Add two minutes a week. Month three or four: add seated leg press, calf raises, and squats to a chair. Standing cardio comes last, often not until month five or six. Leg muscles are your second heart; strong ones pump blood back up for you.
  • Pace yourself with data, not willpower. The model relies on tracking heart rate variability (HRV) every morning with an app like Visible or a wearable. A low HRV morning is a rest day. Pushing on a low day is how people lose a week.
  • Compression. Waist-high compression (20 to 30 mmHg), or an abdominal binder, on the days you have to be upright a lot. Compression on just the calves does not help much; the blood pools in the belly and thighs.
  • Stand up slowly and in stages. Sit on the edge of the bed for a minute. Cross your legs and squeeze your thighs and butt before you stand. Pump your calves while you wait in line.
  • Sleep flat. You will read advice to raise the head of your bed to help you hold on to salt overnight. the model argues against it. Sleeping with your head up means less blood reaches your brain all night, which breaks up deep sleep and turns up inflammation in the brain and nerves, the opposite of what you are trying to fix. Get the salt and water in during the day instead, and let your brain have full blood flow while it repairs.
  • Heat is the enemy. Cool showers, not hot. Cooling vest or a wet bandana in summer. Avoid saunas and hot tubs until you are much better.
  • Eat smaller meals more often. A big meal pulls blood into the gut and away from the brain.
  • Protect your sleep. Same bedtime, dark room, no screens in the last hour. Nerves repair while you sleep and almost never while you are awake.
  • Lower the stress load on purpose. Slow breathing (four seconds in, six out) for five minutes, two or three times a day, directly trains the calming side of your autopilot. It is free and it works.

The sequence the model predicts

Most people feel the salt, water, and compression within days. The nutrients and mast cell calming take four to eight weeks. The nerve repair takes three to nine months, and the exercise program is what locks it in. Progress is not a straight line. Track it monthly, not daily.

This post is educational and is not medical advice. I am a PhD scientist, not a physician. Please work with your healthcare provider, especially before changing salt intake if you have kidney or heart disease, or starting supplements alongside medications.

Framing

Postural orthostatic tachycardia syndrome is defined hemodynamically: a sustained heart rate rise of at least 30 bpm (40 bpm in adolescents) within 10 minutes of standing, without orthostatic hypotension, with symptoms for at least three months. The definition describes a compensatory response and says nothing about etiology. The literature partitions POTS into neuropathic, hyperadrenergic, and hypovolemic subtypes, with substantial overlap, and skin biopsy studies have found reduced intraepidermal and sudomotor nerve fiber density in a large fraction of patients, consistent with a length-dependent autonomic small fiber neuropathy (SFN).

My working model, built from what I see in the cases I have worked through rather than from a single trial, is that most acquired POTS is a small fiber neuropathy produced by three converging insults: inadequate substrate for axonal maintenance, chronic mast cell mediator exposure at the perivascular nerve terminals, and exhaustion of one-carbon (methylation) capacity. Each alone is often tolerated. Together they exceed the repair capacity of unmyelinated C fibers and thinly myelinated A-delta fibers, which have the highest turnover and the least reserve of any neurons in the body. Connective tissue laxity and post-viral priming act as amplifiers.

1. Substrate failure: the axon as a metabolic liability

Small fibers are maintained by continuous axonal transport over distances of up to a meter from a cell body in the dorsal root or sympathetic ganglion. Membrane phospholipid turnover, mitochondrial replacement, and neurotransmitter synthesis at the terminal are all substrate-limited. The nutrients with the best-established links to small fiber integrity:

  • Cobalamin (B12): required by methionine synthase (one-carbon cycle) and methylmalonyl-CoA mutase (odd-chain fatty acid catabolism). Deficiency produces demyelination and axonal degeneration; the autonomic presentation (orthostatic intolerance, gastroparesis) can precede hematologic signs by years. Serum B12 in the 200 to 400 pg/mL range is frequently functionally insufficient; methylmalonic acid and homocysteine are the discriminating markers.
  • Folate (as 5-MTHF): co-substrate for methionine synthase; also regulates tetrahydrobiopterin salvage and therefore nitric oxide synthase coupling in the vascular endothelium. MTHFR C677T and A1298C reduce flux, with the homozygous C677T genotype retaining roughly 30 percent of wild-type activity.
  • Thiamine (B1): pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase cofactor. Thiamine-dependent autonomic neuropathy (beriberi) presents as tachycardia and orthostatic intolerance before peripheral sensory loss. Intake is often marginal in people eating low-carbohydrate or low-legume diets, and absorption is impaired by gut dysbiosis.
  • Pyridoxal-5-phosphate (B6): cofactor for aromatic amino acid decarboxylase (catecholamine and serotonin synthesis), cystathionine beta-synthase (transsulfuration), and sphingolipid synthesis for myelin. Both deficiency and pyridoxine excess cause neuropathy; the active form matters.
  • Riboflavin (B2): FAD cofactor for MTHFR itself. Riboflavin repletion partially rescues the C677T phenotype.
  • Omega-3 fatty acids (DHA especially): 30 to 40 percent of neuronal membrane phospholipid acyl chains; precursors to resolvins and neuroprotectins that terminate neuroinflammation.
  • Choline: phosphatidylcholine and sphingomyelin synthesis; acetylcholine for both sympathetic preganglionic and parasympathetic transmission. The adequate intake (425 to 550 mg) is not met by most diets without eggs or liver.
  • Copper: dopamine beta-hydroxylase cofactor (norepinephrine synthesis) and cytochrome c oxidase. Copper deficiency produces a myeloneuropathy indistinguishable from B12 deficiency and is common after bariatric surgery or with high zinc supplementation.
  • Vitamin E (tocopherols and tocotrienols): the principal lipid-phase antioxidant in neuronal membranes; deficiency causes a spinocerebellar and peripheral axonopathy.
  • Magnesium: NMDA receptor gating, Na/K-ATPase, mast cell stabilization.
  • Iron: ferritin under roughly 50 ng/mL is associated with orthostatic tachycardia independent of anemia, plausibly through reduced tyrosine hydroxylase and prolyl hydroxylase activity.

In the cases I have worked through, I rarely see one isolated deficiency. I see a cluster of low-normal values across four to six of these, in a person whose intake is adequate on paper. Three mechanisms explain the gap: malabsorption from dysbiosis and enteric dysmotility (itself an autonomic sign), increased demand from inflammation and methylation load, and genotype-dependent requirements.

2. Mast cell mediators at the neurovascular junction

Mast cells are resident at perivascular sites and in close apposition to autonomic nerve terminals, with bidirectional signaling: substance P and CGRP from C fibers degranulate mast cells; histamine, tryptase, prostaglandin D2, leukotrienes, and heparin from mast cells act on the nerve terminal and the vessel wall.

The mechanistic contributions to orthostatic intolerance:

  • Histamine at H1 and H2 receptors increases endothelial permeability and produces vasodilation, directly opposing the splanchnic and cutaneous vasoconstriction required on standing. Splanchnic pooling is the dominant hemodynamic lesion in neuropathic POTS.
  • Prostaglandin D2 is a potent vasodilator and the mediator most responsible for flushing. In the people I have worked with, PGD2 and its urinary metabolite (11-beta-PGF2-alpha) and plasma heparin are the markers that come back elevated far more often than serum tryptase or plasma histamine, both of which clear within minutes and are frequently normal between episodes. I no longer consider a normal tryptase to be evidence against mast cell involvement.
  • Tryptase and chymase activate PAR-2 on sensory and autonomic fibers, sensitizing them and promoting neurogenic inflammation.
  • Mediator-driven neuroinflammation is a plausible driver of the small fiber loss itself; chronic histamine and PGD2 exposure activates perineural macrophages and complement.

Mast cell degranulation is also a direct consumer of methylation capacity: histamine is cleared extracellularly by diamine oxidase (DAO, copper and B6 dependent) and intracellularly by histamine N-methyltransferase (HNMT), which uses S-adenosylmethionine as the methyl donor. High histamine flux therefore drains the SAMe pool. This is the hinge between weight two and weight three.

Gut dysbiosis is present in effectively every MCAS person I have worked with. Histamine-producing taxa, reduced short-chain fatty acid producers, and increased permeability all raise the systemic histamine and LPS load that keeps mast cells primed.

3. One-carbon exhaustion

The methylation cycle supplies SAMe for over 200 methyltransferase reactions: HNMT, COMT (catecholamine clearance), phosphatidylethanolamine N-methyltransferase (phosphatidylcholine synthesis for myelin), DNA and histone methylation, and creatine synthesis via guanidinoacetate methyltransferase, which alone consumes roughly 40 percent of daily SAMe. Transsulfuration downstream of homocysteine supplies cysteine for glutathione.

Chronic immune activation increases SAMe demand (polyamine synthesis, lymphocyte proliferation) while inflammation and oxidative stress inhibit methionine synthase directly, since its cobalamin cofactor is oxidized by peroxynitrite. The result is a functional B12 and folate deficiency even with normal serum values: elevated homocysteine, reduced SAMe to SAH ratio, and loss of methyltransferase flux. In this state histamine clearance slows (more mast cell symptoms), phosphatidylcholine synthesis slows (less membrane repair), catecholamine clearance slows (the hyperadrenergic phenotype: tremor, anxiety, palpitations), and glutathione falls (more oxidative stress at the axon).

Genotype matters here. MTHFR, MTR, MTRR, CBS, COMT, and HNMT variants each shift the operating point. My observation is that methylation variants are strongly enriched in the hypermobile cases I have worked through, and that histamine-mediated symptoms improve, sometimes within days, when methylfolate and B12 or SAMe are introduced carefully. I read that as evidence that something in these people I have worked with is taxing methylation past its limit, with the mast cell load being the most likely candidate.

Amplifiers

Connective tissue laxity. In hypermobile EDS and HSD, venous compliance is increased, so the same autonomic signal produces more pooling. Vascular wall laxity also increases shear-driven endothelial activation. These people I have worked with need a larger compensatory response from a smaller autonomic reserve.

Post-viral priming. SARS-CoV-2 produces persistent mast cell activation, autoantibodies against adrenergic and muscarinic receptors in a subset, and direct small fiber injury. I do not think COVID created a new disease; it pushed people who were already carrying two of the three weights into carrying all three.

Autoimmunity. Alpha-1 adrenergic, beta-1 and beta-2 adrenergic, and M2 muscarinic receptor autoantibodies have been reported in POTS cohorts. I read these as a consequence of the same immune activation rather than a separate entity, but they are worth measuring when the picture is strongly hyperadrenergic.

Markers that would test the model

What I actually order or request, beyond the active stand test:

  • Methylmalonic acid, homocysteine, serum and RBC folate, holotranscobalamin if available
  • Ferritin, transferrin saturation, copper, ceruloplasmin, zinc, RBC magnesium, 25-OH vitamin D, plasma thiamine or erythrocyte transketolase activity
  • Omega-3 index
  • Plasma heparin, urinary 11-beta-PGF2-alpha and N-methylhistamine (24-hour, refrigerated), chromogranin A. Tryptase if convenient, interpreted cautiously.
  • Comprehensive stool analysis with calprotectin and short-chain fatty acids
  • Skin biopsy for IENFD and sweat gland fiber density when the diagnosis is contested
  • Relevant SNPs: MTHFR C677T and A1298C, MTR A2756G, MTRR A66G, COMT V158M, HNMT C314T, DAO (AOC1) variants, CBS C699T

What the model predicts: addressing each node

If the model is right, the target is small fiber regeneration, which proceeds at roughly 1 mm per day under favorable conditions and requires removal of the ongoing insult. Expect a 3 to 9 month horizon.

Diet

Target intake of roughly 1.5 times the RDA for the neurotrophic nutrients listed above, from food wherever possible, contingent on normal renal and hepatic function. Daily targets at that multiplier, for a typical adult: protein 1.4 to 1.6 g/kg; B12 4 mcg (functionally far more, given absorption); folate 600 mcg DFE; thiamine 1.8 mg; riboflavin 2 mg; B6 2.5 mg; choline 650 to 800 mg; EPA plus DHA 2 g; magnesium 500 to 600 mg; copper 1.4 mg; vitamin E 22 mg; iron 27 mg (menstruating women) or 12 mg (men, postmenopausal women); sodium 2.4 to 4 g. Distributed across meals:

Meal Nutrient targets Reference meal Substitutions
Breakfast Protein 25 to 30 g; choline 250 mg; B12 1 mcg; riboflavin 0.6 mg; magnesium 100 mg 2 eggs in butter or olive oil, half an avocado, berries, salted Egg-free: 4 oz chicken thigh or ground beef, or 1 cup cottage cheese or Greek yogurt, plus 1 tbsp sunflower lecithin (roughly 250 mg phosphatidylcholine-choline) for the choline that eggs otherwise supply
Lunch Protein 25 to 30 g; EPA plus DHA 1 to 1.5 g; folate 200 mcg; magnesium 150 mg; copper 0.5 mg; iron 6 to 8 mg Salad with 3 to 4 oz sardines or wild salmon, 1 cup lentils or white beans, 1 oz pumpkin seeds, olive oil Mercury: methylmercury burden scales with trophic level and fish age. Sardine, herring, anchovy, and Atlantic mackerel are lowest (typically under 0.05 ppm); canned salmon is low to moderate; fresh or frozen wild salmon and trout are the cleaner swap. Avoid tuna, swordfish, king mackerel. Fish-free: algal DHA/EPA 1 to 2 g with the meal; folate, iron, and copper from legumes, pumpkin seeds, and 1 cup cooked greens
Dinner Protein 30 to 35 g; B12 2 mcg; thiamine 0.5 mg; B6 1 mg; heme iron 3 to 5 mg; zinc 6 mg; folate 200 mcg 5 to 6 oz beef, lamb, or chicken thigh; 1 cup broccoli or asparagus; potato or rice with salt and butter No red meat: chicken thigh or turkey for B vitamins and zinc; 1 cup legumes for iron, paired with a vitamin C source (bell pepper, citrus) to raise non-heme absorption two- to three-fold
Snacks Vitamin E 5 to 8 mg; thiamine; sodium 1 oz sunflower seeds; hard-boiled egg or turkey; bone broth with added salt Egg-free: turkey, nuts, seed butter

Organ meat. 2 to 3 oz of beef or chicken liver weekly, divided over two meals, supplies B12 (roughly 60 mcg per oz), folate, copper (4 mg per oz, the main reason to cap it), retinol, and riboflavin at levels no supplement matches. Desiccated liver is an acceptable substitute: drying removes about 75 percent of mass, so 4 g desiccated liver approximates 1 oz fresh. At 500 to 750 mg per capsule, 2 to 3 oz per week equals 12 to 18 capsules weekly, or 2 to 3 capsules daily with food. Freeze-dried, grass-fed, no excipients. Copper intake from liver should be accounted for before adding supplemental copper.

Sodium and fluid: 6 to 10 g sodium chloride daily (2.4 to 4 g sodium) with 2 to 3 L fluid, front-loaded with 500 mL and 1/4 teaspoon salt before rising. Contraindicated in renal disease, heart failure, and uncontrolled hypertension.

Macronutrient timing: protein 25 to 35 g at each of four to five smaller meals to limit postprandial splanchnic pooling and reactive hypoglycemia; avoid large refined carbohydrate loads, which worsen postprandial tachycardia through insulin-mediated vasodilation.

Histamine restriction trial, four weeks: eliminate aged, fermented, cured, and leftover foods; alcohol; vinegar; tomato, spinach, eggplant; canned fish stored after opening. Cook fresh and freeze same day. Reintroduce systematically. The goal is to lower mediator load during the repair window, not permanent restriction.

Supplements, in the order the model suggests

One agent per week, titrated, is the sequencing that the people I have worked with have tolerated best, because the hyperadrenergic phenotype reacts badly to rapid changes in catecholamine metabolism.

  1. Magnesium glycinate or malate, 200 mg elemental at night, titrating to 400 to 600 mg or bowel tolerance.
  2. Omega-3, 2 to 3 g EPA plus DHA daily, re-esterified triglyceride form, DHA fraction prioritized for neural membrane. Taken with a fat-containing meal: bioavailability of long-chain omega-3 roughly triples with concurrent dietary fat because absorption is bile and micelle dependent.
  3. Methyl-sparing substrates rather than methyl donors: creatine monohydrate 5 g daily and phosphatidylcholine 1,200 to 2,400 mg daily with food. Guanidinoacetate methyltransferase consumes roughly 40 percent of daily SAMe, and phosphatidylethanolamine N-methyltransferase a substantial further fraction when dietary choline is low. Supplying both end products suppresses the corresponding synthesis through feedback and product availability, freeing SAMe for HNMT, COMT, and myelin-related methyltransferases without adding methyl groups to a system that may be unable to dispose of them. In my methylation-limited people I have worked with this pair does more, with fewer adverse reactions, than a methylated B complex.
  4. Non-methylated B complex containing folinic acid (5-formyltetrahydrofolate), riboflavin-5-phosphate, P5P, and thiamine or benfotiamine, started at one-quarter dose and increased by one-quarter weekly to full dose. Folinic acid enters the folate cycle upstream of MTHFR and is converted to 5-MTHF at the rate MTHFR allows, so it supports DNA synthesis and the folate pool without forcing methyl flux.

Methyl trapping, mechanistically. 5-MTHF can only be used by methionine synthase, and methylcobalamin only by methionine synthase and HNMT-adjacent pathways. When downstream capacity is limiting (riboflavin or magnesium insufficiency, oxidized cobalamin from peroxynitrite, slow COMT V158M with reduced catecholamine clearance, or simply a system already at its ceiling), supplied methylfolate accumulates as 5-MTHF that cannot be regenerated to THF, the SAMe:SAH ratio shifts, and the clinical signal is anxiety, insomnia, irritability, palpitations, or headache within 24 to 72 hours of initiation. The literature-supported response is withdrawal, a few days of washout, repletion of the limiting cofactor, and reintroduction with folinic acid and a non-methyl cobalamin. 5. Cobalamin, 1,000 to 2,000 mcg sublingually daily, as hydroxocobalamin plus adenosylcobalamin by default. Hydroxocobalamin is the circulating storage form and is converted intracellularly to both coenzyme forms; adenosylcobalamin is the mitochondrial coenzyme for methylmalonyl-CoA mutase and is relevant to odd-chain fatty acid and branched-chain amino acid catabolism in the axon. Neither carries a methyl group. Adenosylcobalamin plus methylcobalamin is appropriate for people I have worked with who have demonstrated methyl tolerance. Intramuscular hydroxocobalamin 1 mg weekly for 8 weeks when MMA is elevated or SFN is documented. 6. Mitochondrial support, because axonal regeneration is ATP-limited and mitochondrial dysfunction is nearly universal in this population: CoQ10 as ubiquinol 100 to 200 mg with a meal; then acetyl-L-carnitine 500 to 1,500 mg in the morning (ALCAR has direct evidence in small fiber and chemotherapy-induced neuropathy, supports fatty acid transport, and provides an acetyl group for acetylcholine synthesis); then alpha-lipoic acid 300 to 600 mg, R-form preferred, which regenerates glutathione and tocopherol and has the strongest nutraceutical evidence base in diabetic SFN. ALA is withheld in pregnancy, in people I have worked with planning pregnancy, and during breastfeeding, for lack of safety data; CoQ10 and ALCAR are not restricted. 7. Vitamin C, liposomal, 1 to 2 g daily, for mast cell stabilization and as cofactor for dopamine beta-hydroxylase. 8. Apigenin, 50 mg at bedtime, as the primary mast cell stabilizer. Apigenin inhibits mast cell degranulation and IL-6 and TNF release at concentrations comparable to or below luteolin and quercetin, inhibits CD38 (sparing NAD+), and has mild GABA-A positive allosteric activity, which is why it is dosed at night where it supports sleep onset instead of competing with daytime alertness. DAO 10,000 to 20,000 HDU before meals when food-triggered symptoms dominate. Mixed tocotrienols, 100 to 200 mg daily, added after several weeks for membrane-phase antioxidant protection of the regenerating axon. 9. Iron, as bisglycinate 25 to 50 mg every other day with vitamin C, when ferritin is below 50, rechecking at 12 weeks. 10. Copper 1 to 2 mg only when serum copper or ceruloplasmin is low after accounting for liver intake, and never alongside high-dose zinc.

Methylene blue deserves caution in this population; the reaction rate among the MCAS cases I have worked through is high.

Lifestyle

This is at least half of the lever and the only part with randomized trial support for POTS specifically.

  • Graded recumbent exercise. The Levine and CHOP protocols are the model: months one and two are recumbent bike, rowing, or swimming, 3 to 4 sessions weekly, 10 to 20 minutes at a conversational intensity, with weekly increments of 2 to 5 minutes; strength work for the lower body and core begins by month two (seated leg press, calf raises, supine bridges, planks); upright cardio is introduced only after 3 to 5 months. The physiological target is expansion of plasma volume and cardiac mass and improved venous return from the skeletal muscle pump. Progress is gated by symptoms, not by schedule.
  • Objective pacing. Morning HRV (RMSSD) via a wearable or the Visible app. A reading more than one standard deviation below the rolling baseline is a rest day. Post-exertional malaise is the signal that intensity exceeded capacity; it costs a week and should be treated as a sequence error, not as a target.
  • Compression: waist-high 20 to 30 mmHg or an abdominal binder; splanchnic compression matters more than calf compression.
  • Counter-maneuvers: leg crossing with gluteal and thigh contraction, squatting, calf pumping, which raise cardiac output 10 to 20 percent transiently.
  • No head-of-bed elevation. It is standard advice, on the rationale of reducing nocturnal natriuresis. The model argues against it. Sustained head-up tilt during sleep lowers cerebral perfusion pressure in a population whose cerebral blood flow is already reduced on standing; the predictable consequences are fragmented slow-wave sleep, impaired glymphatic clearance, and increased CNS inflammatory signaling, which work directly against small fiber repair. Plasma volume is managed with daytime sodium and fluid loading and compression instead, and the person sleeps flat.
  • Thermal management: avoid heat exposure, hot showers, sauna; cooling garments in summer.
  • Meal structure: five small meals; no large carbohydrate loads; a 10 to 15 minute seated rest after meals.
  • Sleep: fixed schedule, 8 to 9 hours, dark and cool. Axonal repair and glymphatic clearance are sleep-dependent.
  • Vagal training: slow breathing at 5 to 6 breaths per minute, 5 minutes two to three times daily, increases baroreflex sensitivity; it is one of the few non-pharmacologic interventions that directly raises parasympathetic tone.
  • Environmental load: reduce fragrance, VOC, and mold exposure, which are mast cell triggers; filtered water; HEPA filtration in the bedroom.
  • Where prescribed medications fit: many people I have worked with are on antihistamines, beta blockers, fludrocortisone, midodrine, or ivabradine. These are useful bridges and nothing here conflicts with them, but the goal of the nutritional and lifestyle sequence is to reduce the need for them over 6 to 12 months, in coordination with their prescriber.

Markers to follow over time

Active stand test and symptom burden monthly; MMA, homocysteine, ferritin, and mast cell markers at 12 weeks; omega-3 index and copper at 6 months. The expected sequence is: hemodynamic improvement from volume and compression within one to two weeks; reduction in mast cell symptoms within four to eight weeks of mediator control and methylation support; sustained improvement in orthostatic tolerance tracking with the exercise program from month three onward.

Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. The sequences described are what this model predicts would address each node if the model is correct, with the supporting literature cited in the text; they are offered for discussion with a qualified clinician, who should manage any agent with contraindications or interactions.